Regis Healthcare Crecimiento futuro

Future controles de criterios 5/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Regis Healthcare de 37.4% y 7.9% por año respectivamente. Se prevé que el BPA crezca en un 39.1% al año. Se espera que la rentabilidad financiera sea de 133% en 3 años.

Información clave

37.4%

Tasa de crecimiento de los beneficios

39.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	25.0%
Tasa de crecimiento de los ingresos	7.9%
Rentabilidad financiera futura	133.0%
Cobertura de analistas	Good
Última actualización	18 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Sep 12

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02

Previsiones de crecimiento de beneficios e ingresos

ASX:REG - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2027	1,299	83	170	221	7
6/30/2026	1,218	65	127	202	7
6/30/2025	1,142	49	2	197	7
6/30/2024	1,014	-21	187	252	N/A
3/31/2024	947	-18	159	224	N/A
12/31/2023	880	-15	132	195	N/A
9/30/2023	830	-22	93	150	N/A
6/30/2023	781	-28	54	105	N/A
3/31/2023	761	-45	34	78	N/A
12/31/2022	741	-61	14	50	N/A
9/30/2022	733	-50	41	82	N/A
6/30/2022	725	-39	68	115	N/A
3/31/2022	719	-16	N/A	N/A	N/A
12/31/2021	713	8	104	143	N/A
9/30/2021	707	14	96	124	N/A
6/30/2021	701	20	88	105	N/A
3/31/2021	700	8	N/A	N/A	N/A
12/31/2020	699	-4	86	105	N/A
9/30/2020	688	-2	87	116	N/A
6/30/2020	678	-1	88	127	N/A
3/31/2020	655	21	111	156	N/A
12/31/2019	661	39	134	186	N/A
9/30/2019	654	45	144	203	N/A
6/30/2019	647	51	155	220	N/A
3/31/2019	632	51	101	204	N/A
12/31/2018	617	50	47	188	N/A
9/30/2018	606	52	-13	161	N/A
6/30/2018	594	54	-74	134	N/A
3/31/2018	586	56	N/A	129	N/A
12/31/2017	577	57	N/A	124	N/A
9/30/2017	571	59	N/A	138	N/A
6/30/2017	565	61	N/A	151	N/A
3/31/2017	547	55	N/A	151	N/A
12/31/2016	529	50	N/A	152	N/A
9/30/2016	505	48	N/A	143	N/A
6/30/2016	481	47	N/A	134	N/A
3/31/2016	468	59	N/A	146	N/A
12/31/2015	455	71	N/A	159	N/A
9/30/2015	446	64	N/A	143	N/A
6/30/2015	438	58	N/A	127	N/A
3/31/2015	433	28	N/A	119	N/A
12/31/2014	428	-1	N/A	110	N/A
9/30/2014	419	0	N/A	122	N/A
6/30/2014	410	1	N/A	135	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que REG sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.6%).

Beneficios vs. Mercado: Se prevé que REG sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que REG sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (7.9% al año) de REG crezcan más rápidamente que los del mercado Australian (5.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 7.9% al año) de REG crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de REG sea muy elevada dentro de 3 años (133%).

Regis Healthcare Crecimiento futuro

Future controles de criterios 5/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.5% to AU$4.74

Price target increased by 8.5% to AU$4.37

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Price target increased by 11% to AU$3.07

Recent updates

Regis Healthcare Limited Announces Retirement of Bryan Dorman as Non-Executive Director, Effective 26 November 2024

Regis Healthcare Limited, Annual General Meeting, Nov 26, 2024

Regis Healthcare Limited (ASX:REG) agreed to acquire Two residential aged care homes in Capel Sound and Mornington from Ti Tree Operations Pty Ltd for AUD 35.5 million.

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Final dividend of AU$0.066 announced

Price target increased by 7.5% to AU$4.74

Full year 2024 earnings: Revenues exceed analyst expectations

Regis Healthcare Limited to Report Second Half, 2024 Results on Aug 26, 2024

Price target increased by 8.5% to AU$4.37

Non-Executive Director recently sold AU$68m worth of stock

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Upcoming dividend of AU$0.063 per share

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

First half dividend increased to AU$0.063

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited (ASX:REG) agreed to acquire Cpsm Pty Ltd for AUD 74.2 million.

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Price target increased by 8.7% to AU$2.74

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased by 8.8% to AU$2.59

Upcoming dividend of AU$0.075 per share at 3.8% yield

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Consensus EPS estimates fall by 14%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on September 27, 2023

Regis Healthcare Limited Announces the Resignation of Rebecca Dean as Company Secretary

Regis Healthcare Limited, Annual General Meeting, Oct 24, 2023

Regis Healthcare Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

Price target increased by 7.6% to AU$2.33

Consensus EPS estimates fall by 18%

Upcoming dividend of AU$0.02 per share at 3.7% yield

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: AU$0.086 loss per share (vs AU$0.012 loss in 1H 2022)

Regis Healthcare Limited to Report First Half, 2023 Results on Feb 24, 2023

Consensus forecasts updated

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Upcoming dividend of AU$0.023 per share

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Fiscal Year 2022 Final Dividend, Payable on September 30, 2022

Regis Healthcare Limited, Annual General Meeting, Oct 25, 2022

Consensus forecasts updated

Consensus forecasts updated

Regis Healthcare Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Now 21% undervalued

Consensus forecasts updated

Upcoming dividend of AU$0.035 per share

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Declares Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on April 8, 2022

Upcoming dividend of AU$0.046 per share

Full year 2021 earnings released

Price target increased to AU$2.49

Consensus forecasts updated

Insufficient new directors

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

Price target increased to AU$2.22

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

Regis Healthcare Limited to Report Fiscal Year 2021 Results on Aug 31, 2021

Regis Healthcare Limited, Annual General Meeting, Oct 26, 2021

Regis Healthcare Limited to Report First Half, 2021 Results on Feb 24, 2021